In turn, inhibition of intestinal FXR in obese mice decreases ceramide levels both in the intestine and circulation, which resolves hepatic steatosis and enhances the thermogenic capacity of adipose tissue, in part through increased mitochondrial uncoupling and adipose tissue browning to ameliorate obesity and insulin resistance [219–221]. This evidence concerns the gene NR1H4 and Obesity.